Completed PHASE1 INTERVENTIONAL 2-arm NCT02266784

Contingency Management, Quitting Smoking, and ADHD (ADQUIT)

Smoking/Nicotine Dependence in Attention Deficit Hyperactivity Disorder (ADHD)

Sponsor: Duke University

Conditions Cigarette Smoking Smoking Cessation

Interventions Contingency Management (CM) Supportive Counseling Transdermal nicotine skin patches (i.e. Habitrol)

Updated 10 times since 2017 Last updated: Oct 15, 2020 Started: Oct 31, 2014 Primary completion: Dec 8, 2017 Completion: Dec 8, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02266784, this PHASE1 trial focuses on Cigarette Smoking and Smoking Cessation and remains completed. Sponsored by Duke University, it has been updated 10 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Nov 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Mar 2020 — Nov 2020 [monthly]

Recruiting PHASE1

▶ Show 5 earlier versions

Jun 2019 — Mar 2020 [monthly]

Recruiting PHASE1
Mar 2019 — Jun 2019 [monthly]

Recruiting PHASE1
Dec 2018 — Mar 2019 [monthly]

Recruiting PHASE1
Jun 2018 — Dec 2018 [monthly]

Recruiting PHASE1
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE1

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duke University
National Institute on Drug Abuse (NIDA)

Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States